ABOUT THIS EVENT
Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve quality of life for cancer patients, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Chandler D. Robinson, Co-Founder & CEO, rings the Opening Bell.